Bliss GVS Pharma Limited
Bliss GVS Pharma Limited scores highest on Nitro (88) and lowest on Anchor (33). Its PosiPenta is 53.74 out of 100, around the middle of similar companies.
On the Penta Grid this week, Bliss GVS Pharma Limited is Grid #60 of 170 in the Healthcare sector in India, and Grid #850 of 2,397 in India.
Compared with similar companies in the Healthcare sector in India.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Bliss GVS Pharma Limited | 53.74 | 35 | 50 | 88 | 64 | 33 |
| Supriya Lifescience Limited | 59.28 | 44 | 64 | 60 | 79 | 51 |
| Morepen Laboratories Limited | 42.11 | 39 | 21 | 70 | 48 | 32 |
| Entero Healthcare Solutions Limited | 47.70 | 44 | 74 | 64 | 26 | 30 |
| Sanofi India Limited | 56.38 | 52 | 56 | 9 | 90 | 75 |
| Kovai Medical Center and Hospital Limited | 69.22 | 61 | 98 | 75 | 58 | 54 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 51.75 |
| P/B ratio | 5.81 |
EEarnings
| Trailing EPS | ₹12.60 |
| Forward EPS | — |
NNitro
| Price | 652.00 |
| 52-week high | 739.90 |
| 52-week low | 118.00 |
| Fall from 52-week high | 11.9% |
TTorque
| Return on equity (ROE) (calculated) | 11.23% |
| Debt-to-equity | 0.02 |
AAnchor
| Beta (price swings) | 1.22 |
| Market cap | ₹6,932 Cr |
| Promoter holding | 35.01% |
| Dividend yield | 0.23% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Bliss GVS Pharma Limited's PosiPenta score?
Bliss GVS Pharma Limited's PosiPenta is 53.74 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Bliss GVS Pharma Limited stand on the Penta Grid?
On the Penta Grid this week, Bliss GVS Pharma Limited is Grid #60 of 170 in the Healthcare sector in India, and Grid #850 of 2,397 in India.
Which PosiPenta pillar is strongest for Bliss GVS Pharma Limited?
Nitro (momentum), with a score of 88 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Bliss GVS Pharma Limited?
Anchor (stability and dividends), with a score of 33 out of 100: weaker than most similar companies.
Has Bliss GVS Pharma Limited's PosiPenta changed since last week?
Yes, it fell 0.52 points, from 54.26 to 53.74.
PositoAI is for research and education only and is not investment advice.